CONGENITAL EMPHYSEMA

This adverse event was reported 26 times

These drugs are most commonly taken by patients reporting CONGENITAL EMPHYSEMA:

# Drug Count
0 ACETAZOLAMIDE 8
1 ACETAZOLAMIDE SODIUM 8
2 ESCITALOPRAM 5
3 ESCITALOPRAM OXALATE 5
4 ESCITSLOPRAM 4
5 FOLIC ACID 4
6 INSULIN GLARGINE 4
7 LAMOTRIGINE 3
8 QUETIAPINE 3
9 ACETAMINOPHEN 2
See all common drugs associated with CONGENITAL EMPHYSEMA

CONGENITAL EMPHYSEMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PORACTANT ALFA 1 0.0014
1 ACETAZOLAMIDE SODIUM 8 0.0013
2 NITROFURANTOIN MONOHYDRATE/MACROCRYSTALLINE 1 0.0002
3 AMPICILLIN INJECTION 1 0.0001
4 GENTAMICIN SULFATE 2 0.0001
5 AMPICILLIN 1 0.0001
6 SODIUM BICARBONATE INJECTION, 2 0.0001
7 BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE 1 0.0000
8 ESCITALOPRAM 5 0.0000
9 PAROXETINE HYDROCHLORIDE 1 0.0000
See all drugs enriched for association with CONGENITAL EMPHYSEMA

CONGENITAL EMPHYSEMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Surfactant [EPC] 1 0.0009
1 Carbonic Anhydrase Inhibitor [EPC] 8 0.0004
2 Mood Stabilizer [EPC] 3 0.0000
3 Anti-epileptic Agent [EPC] 3 0.0000
4 Vitamin D [EPC] 4 0.0000
5 Vitamin B12 [EPC] 4 0.0000
6 Vitamin C [EPC] 4 0.0000
7 Insulin Analog [EPC] 4 0.0000
8 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
9 Expectorant [EPC] 1 0.0000
See all drug classes enriched for association with CONGENITAL EMPHYSEMA